Source:http://linkedlifedata.com/resource/pubmed/id/19806479
Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
3
|
pubmed:dateCreated |
2010-10-19
|
pubmed:abstractText |
Heart type fatty acid binding protein (H-FABP) is a major cytoplasmic low-molecular weight protein and released into the circulation when the myocardium is injured. Previous studies have demonstrated that H-FABP is closely associated with acute coronary syndrome, hypertrophic and dilated cardiomyopathy, heart failure, stroke, obstructive sleep apnea syndrome, pulmonary embolism. The aim of this study was to investigate serum H-FABP value in the patients with metabolic syndrome (MetS). We measured serum H-FABP levels in 55 consecutive patients with MetS, and 73 age-matched control subjects by using a sandwich enzyme-linked immunosorbent assay. Serum H-FABP levels were significantly higher in patients with MetS than in control subjects 18.37 ± 13.0 and 7.9 ± 6.5 ng/ml, respectively, (P < 0.001). Serum H-FABP levels were significantly higher in patients with diabetic MetS than in without diabetic MetS, 24.0 ± 10.2 and 13.9 ± 12.6 ng/ml, respectively, (P: 0,003). There were statistically significant differences between patients without diabetic MetS and control subjects, 13.8 ± 12.6 and 7.9 ± 6.5 ng/ml, respectively, (P = 0.023). Patients with MetS have an increased risk of death from cardiovascular diseases. H-FABP seems to be a marker that will enable the detection of cardiac injury in the early asymptomatic period in patients with MetS.
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:month |
Dec
|
pubmed:issn |
1559-0100
|
pubmed:author | |
pubmed:issnType |
Electronic
|
pubmed:volume |
36
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
433-7
|
pubmed:meshHeading |
pubmed-meshheading:19806479-Adult,
pubmed-meshheading:19806479-Biological Markers,
pubmed-meshheading:19806479-Cardiovascular Diseases,
pubmed-meshheading:19806479-Case-Control Studies,
pubmed-meshheading:19806479-Diabetes Complications,
pubmed-meshheading:19806479-Fatty Acid-Binding Proteins,
pubmed-meshheading:19806479-Female,
pubmed-meshheading:19806479-Humans,
pubmed-meshheading:19806479-Hypertension,
pubmed-meshheading:19806479-Male,
pubmed-meshheading:19806479-Metabolic Syndrome X,
pubmed-meshheading:19806479-Middle Aged
|
pubmed:year |
2009
|
pubmed:articleTitle |
Serum heart type fatty acid binding protein levels in metabolic syndrome.
|
pubmed:affiliation |
Department of Internal Medicine, Ankara Education and Research Hospital, Ministry of Health, Ankara, Turkey. erdem_akbal@mynet.com
|
pubmed:publicationType |
Journal Article
|